T

Transchem

500422 BSE

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

4
  • Stock is trading at 5.58 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 5.98% over last 3 years.
  • Earnings include an other income of Rs.12.7 Cr.

Growth Rate

Revenue Growth
-100%
Net Income Growth
48% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0.41
0
0
0.21
2.42
0
0
0
0
0
Expenses
0.4
0.39
0.5
0.86
0.27
0.37
0.54
2.9
0.29
0.75
1.31
1.31
0.7
Operating Profit
-0.4
-0.39
-0.5
-0.45
-0.27
-0.37
-0.33
-0.48
-0.29
-0.75
-1.31
-1.31
-0.7
OPM %
—
—
—
-109.76%
—
—
-157.14%
-19.83%
—
—
—
—
—
Other Income
1.53
1.69
2.02
2.16
2.47
2.31
2.19
1.56
1.64
1.68
2.25
3.7
5.11
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0.01
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0.05
PBT
1.13
1.3
1.52
1.71
2.2
1.94
1.86
1.08
1.35
0.93
0.94
2.39
4.35
Tax %
24.78%
25.38%
25.66%
26.9%
24.09%
25.26%
25.27%
32.41%
26.67%
27.96%
43.62%
12.55%
21.38%
Net Profit
0.85
0.97
1.14
1.25
1.66
1.44
1.39
0.73
0.99
0.68
0.53
2.09
3.42
EPS in Rs
0.69
0.79
0.93
1.02
1.36
1.18
1.14
0.6
0.81
0.56
0.43
1.71
2.79
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
0
0
-0.05
-0.2
0
0.34
2.63
0
0
Expenses
0.78
0.93
0.98
1.69
1.18
1.39
1.88
2.54
1.73
2.08
4.09
3.63
4.07
Operating Profit
-0.78
-0.93
-0.98
-1.69
-1.18
-1.39
-1.93
-2.74
-1.73
-1.74
-1.46
-3.63
-4.07
OPM %
—
—
—
—
—
—
—
—
—
-511.76%
-55.51%
—
—
Other Income
2.09
1.97
1.78
2.11
2.75
2.76
26.82
6.66
4.24
7.4
8.53
9.25
12.74
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0.01
Depreciation
1.07
1.02
1.02
0.97
0.8
0.57
0.12
0.01
0.01
0.01
0.01
0.01
0.05
PBT
0.24
0.02
-0.22
-0.55
0.77
0.8
24.77
3.91
2.5
5.65
7.06
5.61
8.61
Tax %
45.83%
-150%
0%
116.36%
61.04%
47.5%
2.5%
26.6%
50.8%
25.66%
26.06%
23.53%
—
Net Profit
0.12
0.05
-0.22
-1.19
0.31
0.41
24.15
2.87
1.24
4.2
5.23
4.3
6.72
EPS in Rs
0.1
0.04
-0.18
-0.97
0.25
0.33
19.73
2.34
1.01
3.43
4.27
3.51
5.49
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
12.24
Reserves
26.11
26.15
25.75
24.57
25.74
24.53
50.7
54.06
53.6
63.41
67.08
71.34
Borrowings
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0.22
0.23
0.17
0.17
0.39
0.3
0.48
0.51
0.39
0.66
0.4
4.15
Total Liabilities
38.57
38.62
38.16
36.98
38.37
37.07
63.42
66.81
66.23
76.31
79.72
87.73
Fixed Assets
8.4
7.42
6.4
5.43
4.27
3.7
0.11
0.1
0.09
0.09
0.05
0.02
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
27.5
28.01
29.79
10.21
5.93
3.69
8.69
8.82
8.23
8.91
2.04
1.97
Other Assets
2.67
3.19
1.97
21.34
28.17
29.68
54.62
57.89
57.91
67.31
77.63
85.74
Total Assets
38.57
38.62
38.16
36.98
38.37
37.07
63.42
66.81
66.23
76.31
79.72
87.73
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.94
1.08
0.55
-19.79
10.34
-0.63
-27.72
21.91
1.22
-39.31
36
-2.89
Investing
-1.21
-0.26
-1.51
19.78
5.73
0.67
23.06
0.6
-0.94
5.12
6.02
1.65
Financing
0
0
0
0
0
0
0
0
0
0
0
0
Net Cash Flow
-0.27
0.83
-0.95
-0.01
16.07
0.04
-4.66
22.51
0.28
-34.18
42.02
-1.24
Free Cash Flow
0.94
1.04
0.55
-19.79
10.53
-0.63
-1.79
21.91
1.22
-39.31
36.53
-1.31
CFO/OP
-121
-116
-56
1,165
-897
0
1,401
-853
-132
2,182
-2,618
47
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
—
—
0
0
—
440
376
—
Inventory Days
—
35,770
32,485
—
—
—
-511
-274
—
0
0
—
Days Payable
—
0
0
—
—
—
—
—
—
—
—
—
Cash Conversion Cycle
—
—
—
—
—
—
-511
-274
—
440
376
—
Working Capital Days
—
—
—
—
—
—
3,11,418
42,705
—
71,422
4,856
—
ROCE %
0.63%
0.05%
-0.58%
-1.47%
1.63%
2.03%
4.61%
4.22%
3.5%
7.99%
9.11%
6.9%

Shareholding Pattern

DIIs0.01%Promot.56.45%FIIs0.03%Public43.52%As ofJun 2026

Documents

Frequently Asked Questions about Transchem

What does Transchem Ltd do?
Transchem Ltd has transitioned from mushroom manufacturing and exports to financial services. After selling its non-operational Pune mushroom undertaking in 2020, it primarily earned through inter-corporate deposits and treasury investments.[1][2]
Where is Transchem Ltd (TRANSCHEM) listed?
Transchem Ltd trades under code 500422 on the BSE.
Which sector does Transchem Ltd belong to?
Transchem Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Transchem Ltd has transitioned from mushroom manufacturing and exports to financial services. After selling its non-operational Pune mushroom undertaking in 2020, it primarily earned through inter-corporate deposits and treasury investments.[1][2]

Website transchem.net
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TRANSCHEM.md for Transchem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List